Key Insights

Highlights

Success Rate

58% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 87/100

Termination Rate

27.8%

5 terminated out of 18 trials

Success Rate

58.3%

-28.2% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

43%

3 of 7 completed with results

Key Signals

3 with results58% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (7)
P 1 (1)
P 2 (2)

Trial Status

Completed7
Terminated5
Recruiting3
Unknown1
Active Not Recruiting1
Withdrawn1

Trial Success Rate

58.3%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT06898333Recruiting

Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening

NCT04699188Phase 1Active Not Recruiting

Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

NCT07146568Not ApplicableRecruiting

Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital

NCT05857995Not ApplicableRecruiting

Precision Lung Cancer Survivorship Care Intervention

NCT04889989Not ApplicableTerminatedPrimary

Microwave Ablation in Chinese Patients With Lung Tumors

NCT02549638Terminated

Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma

NCT02673021Not ApplicableTerminated

MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)

NCT01860898Not ApplicableCompleted

A Phase I Study of iPS Cell Generation From Patients With COPD

NCT02410603Completed

Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer

NCT03603652Not ApplicableTerminated

NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung

NCT03713099Not ApplicableWithdrawnPrimary

NEUWAVE Flexible Probe Study #2

NCT00780611CompletedPrimary

Investigating the Improvement in 4D CT Images Using AV Biofeedback

NCT02370303Completed

A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System

NCT02715102TerminatedPrimary

Circulating Tumor DNA in Patients at High Risk for Lung Cancer

NCT01785537Unknown

The Efficacy and Safety of Electronic Cigarettes: a 5-year Follow-up Study

NCT01109524Phase 2Completed

Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer

NCT00716157Completed

Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation

NCT00328588Phase 2Completed

LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy

Showing all 18 trials

Research Network

Activity Timeline